IN2012DN00235A - - Google Patents
Info
- Publication number
- IN2012DN00235A IN2012DN00235A IN235DEN2012A IN2012DN00235A IN 2012DN00235 A IN2012DN00235 A IN 2012DN00235A IN 235DEN2012 A IN235DEN2012 A IN 235DEN2012A IN 2012DN00235 A IN2012DN00235 A IN 2012DN00235A
- Authority
- IN
- India
- Prior art keywords
- progression
- prevention
- delay
- treatment
- invention concerns
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C07D239/96—Two oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22794009P | 2009-07-23 | 2009-07-23 | |
| PCT/EP2010/060733 WO2011009951A1 (en) | 2009-07-23 | 2010-07-23 | 1h-quinazoline-2, 4 -diones for use in the treatment of neuronal ceroid lipofuscinosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN00235A true IN2012DN00235A (ja) | 2015-05-01 |
Family
ID=42671655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN235DEN2012 IN2012DN00235A (ja) | 2009-07-23 | 2010-07-23 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20120122903A1 (ja) |
| EP (1) | EP2456442A1 (ja) |
| JP (1) | JP2012533605A (ja) |
| KR (1) | KR20120052341A (ja) |
| CN (1) | CN102470137A (ja) |
| AU (1) | AU2010274921B2 (ja) |
| BR (1) | BR112012001258A2 (ja) |
| CA (1) | CA2768333A1 (ja) |
| IN (1) | IN2012DN00235A (ja) |
| MX (1) | MX2012000956A (ja) |
| RU (1) | RU2012106426A (ja) |
| WO (1) | WO2011009951A1 (ja) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012137982A2 (en) * | 2011-04-05 | 2012-10-11 | Takeda Pharmaceutical Company Limited | Sulfonamide derivative and use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9400680D0 (en) * | 1994-01-14 | 1994-03-09 | Sandoz Ltd | Improvements in or relating to organic compounds |
| GB0416730D0 (en) * | 2004-07-27 | 2004-09-01 | Novartis Ag | Organic compounds |
| GB0507298D0 (en) * | 2005-04-11 | 2005-05-18 | Novartis Ag | Organic compounds |
-
2010
- 2010-07-23 BR BR112012001258A patent/BR112012001258A2/pt not_active IP Right Cessation
- 2010-07-23 WO PCT/EP2010/060733 patent/WO2011009951A1/en active Application Filing
- 2010-07-23 MX MX2012000956A patent/MX2012000956A/es not_active Application Discontinuation
- 2010-07-23 RU RU2012106426/04A patent/RU2012106426A/ru not_active Application Discontinuation
- 2010-07-23 CA CA2768333A patent/CA2768333A1/en not_active Abandoned
- 2010-07-23 IN IN235DEN2012 patent/IN2012DN00235A/en unknown
- 2010-07-23 JP JP2012521055A patent/JP2012533605A/ja active Pending
- 2010-07-23 US US13/384,280 patent/US20120122903A1/en not_active Abandoned
- 2010-07-23 KR KR1020127004575A patent/KR20120052341A/ko not_active Application Discontinuation
- 2010-07-23 EP EP10734746A patent/EP2456442A1/en not_active Withdrawn
- 2010-07-23 CN CN2010800334750A patent/CN102470137A/zh active Pending
- 2010-07-23 AU AU2010274921A patent/AU2010274921B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU2010274921A1 (en) | 2012-02-02 |
| EP2456442A1 (en) | 2012-05-30 |
| CN102470137A (zh) | 2012-05-23 |
| BR112012001258A2 (pt) | 2016-02-10 |
| AU2010274921B2 (en) | 2014-08-14 |
| RU2012106426A (ru) | 2013-08-27 |
| US20120122903A1 (en) | 2012-05-17 |
| JP2012533605A (ja) | 2012-12-27 |
| CA2768333A1 (en) | 2011-01-27 |
| WO2011009951A1 (en) | 2011-01-27 |
| KR20120052341A (ko) | 2012-05-23 |
| MX2012000956A (es) | 2012-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE032897T2 (hu) | Összeállítás férfi szexuális zavar kezelésére | |
| GB201017345D0 (en) | Receptor antagonists | |
| WO2011009890A3 (en) | Use of azabicycloalkyl derivatives or pyrrolidine - 2 - one derivatives for the treatment or prevention of ataxia | |
| EP2411001A4 (en) | P2X3 RECEPTOR ANTAGONISTS FOR PAIN TREATMENT | |
| IL208895A0 (en) | Nmda receptor antagonists for the treatment of neuropsychiatric disorders | |
| EP2173344A4 (en) | TREATMENT OR PROPHYLAXIS OF NEUROLOGICAL OR NEUROPSYCHIATRIC DISORDERS BY OCULAR ADMINISTRATION | |
| EP2410857A4 (en) | ANTAGONISTS OF THE P2X3 RECEPTOR FOR THE TREATMENT OF PAIN | |
| WO2011005942A3 (en) | Oligonucleotide-based compounds as inhibitors of toll-like receptors | |
| DOP2007000068A (es) | Compuestos de amino-pirimidina 2,6-sustituidos-4-monosustituidos como antagonistas del receptor de prostaglandina d2 | |
| WO2008095086A3 (en) | Topiramate plus naltrexone for the treatment of addictive disorders | |
| IL211678A0 (en) | Smoothened antagonism for the treatment of hedgehog pathway-related disorders | |
| IN2012DN00572A (ja) | ||
| FR2951637B1 (fr) | Table pour massages de personnes allongees ou assises. | |
| MY150600A (en) | Use of opioid antagonists for treating urinary retention | |
| IL218971A0 (en) | Sulfoxide derivatives for the treatment of tumours | |
| MX2013011490A (es) | Derivados de piridopirazina y su uso. | |
| HUE045270T2 (hu) | FLT3 receptor anatgonisták fájdalom rendellenességek kezelésére | |
| IL206881A0 (en) | Formulations for the treatment of mucositis induced by antitumor or immunosuppressive therapy | |
| EP2411042A4 (en) | Tissue kallikrein for the treatment of pancreatic cell dysfunction | |
| EA201170700A1 (ru) | Тетразамещенные пиридазины в качестве антагонистов пути hedgehog | |
| CL2012001606A1 (es) | Compuestos derivados de tiazoles bicíclicos como moduladores alostéricos de receptores mglur5; composición farmacéutica que los comprende; procedimiento de preparación de la composición farmacéutica; combinación farmacéutica; y uso del compuesto en la prevención, tratamiento o profilaxis de trastornos neurológicos o psiquiátricos. | |
| GB0715790D0 (en) | Drug combination for the treatment of sialorrhoea | |
| PH12017500910A1 (en) | Use of sigma receptor ligands in osteoarthritis | |
| IN2012DN00235A (ja) | ||
| UA96574C2 (ru) | Использование ивабрадина для получения лекарств, предназначенных для лечения эндотелиальной дисфункции |